Rationale: Mitochondria produce ATP, especially critical for survival of highly aerobic cells such as cardiac myocytes. Conversely, opening of mitochondrial high-conductance and long-lasting permeability transition pores (mPTP) causes respiratory uncoupling, mitochondrial injury and cell death. However, lowconductance and transient mPTP openings (tPTP) influx, by mPTP inhibitor cyclosporine A, sanglifehrin and in cyclophilin D knockout mice. These tPTP events were 57 ± 5 s in duration, but were rare (occurring in <0.1% of myocyte mitochondria at any moment) such that the overall energetic cost to the cell is minimal. The tPTP pore size is much smaller than for permanent mPTP, as neither Rhod-2 nor calcien (600 Da) were lost. Thus, proteins and even molecules the size of NADH (663 Da) will be retained during these tPTP.
INTRODUCTION
Mitochondria sustain cellular life through energy production, 1 but also mediate programmed cell death. 2 ATP production is mainly via cellular respiration, which is driven by the voltage gradient (ΔΨ m ) across the inner mitochondrial membrane (IMM), that drives proton flux through the F 0 F 1 -ATP synthase. Extremely low resting IMM permeability is critical to maintain high ΔΨ m and ATP synthesis rate in living cells. However, under certain stresses, the IMM undergoes a permeability transition pore opening (mPTP), abolishing ΔΨ m and allowing molecules of up to 1500 Da in size to freely permeate. 3, 4 This causes respiratory uncoupling, metabolite loss (e.g., NADH), cessation of ATP synthesis, increased ATP consumption (via F 0 F 1 -ATP synthase), and mitochondrial and cell death. 5 The molecular identity of mPTP is unknown, but F 0 F 1 -ATP synthase dimers have been proposed as a candidate. 6 Much work has shown that mPTP inhibition by cyclosporine (CsA) [7] [8] [9] or by genetic ablation of a critical mPTP associated protein, cyclophilin D (CypD), protects against mPTP and cell death in response to ischemia-reperfusion injury and amyotrophic lateral sclerosis.
8-11
Thus, mPTP is an attractive drug target to protect against cardiac injury. However, mPTP inhibition by CsA during ischemia preconditioning (IPC) abolished the protective effect of IPC. 10, 11 Moreover, chronic mPTP inhibition leads to mitochondrial Ca 2+ overload and cardiac dysfunction, 12 raising the idea that some mPTP openings might be beneficial by allowing Ca overload. 2, 13 Unlike prolonged or permanent mPTP (pPTP) openings, these could limit metabolite loss and allow full mitochondrial recovery. Until now, evidence of tPTP openings is restricted to inferences from isolated in vitro mitochondria, mostly in suspensions.
13-16
Here we continuously monitor ~800 individual mitochondria in confocal imaging planes of adult cardiac myocytes in physiological conditions, and quantitatively characterize single tPTP openings in mitochondria by measuring [Ca 2+ ] mito and ΔΨ m . These MitoWinks are quite rare, last for ~57 s, do not allow solutes >600 Da through (e.g. not NADH) and are modulated by Ca 2+ , reactive oxygen species (ROS), CypD and CsA like larger pPTP events. 17, 18 MitoWinks may serve a physiological role to protect cells against mitochondrial Ca 2+ overload or alleviate the cells from accumulated ROS damage.
METHODS
Detailed Methods are in the Online Supplement at http://circres.ahajournals.org.
RESULTS

Transient PTP openings in single mitochondria during cyclical SR Ca
2+ release.
To simultaneously assess mPTP-mediated transient Ca 2+ release events in 500-1,000 individual mitochondria in situ, we monitored [Ca 2+ ] mito using Rhod-2 and 2-D confocal microscopy in cardiac myocytes during spontaneous sarcoplasmic reticulum (SR) Ca 2+ releases (Fig 1A-B (Fig 1C) , and these events were suppressed by the mPTP inhibitor cyclosporine A (CsA; Fig  1D) and sanglifehrin A (Online Figure II) . This demonstrates mPTP-mediated events under relatively physiological conditions.
To further examine these events, we used Na + -free internal solution to inhibit mNCX. Fig 1E ] i clamped using 0.5 mmol/L EGTA, and SR function suppressed by 5 µmol/L thapsigargin. This is a typically used protocol, and may simulate tonic cellular Ca 2+ loading. The frequency of putative tPTP events was similar for both SR release and Ca-clamp protocols, and in both cases 10 µmol/L CsA inhibited the events, consistent with them being tPTP openings (Fig 1F) . These events are rare (~210 -4 per mitochondria per min) under basal conditions, and our ability to monitor nearly 1,000 individual mitochondria continuously for 10 min was critical for observing these events. The average duration of these tPTP openings is 57  5 s (Fig 1I) , and this allows us to quantify that only 0.02% of the myocyte mitochondria experience this tPTP at any moment under physiological conditions (Fig 1H) . This means that 99.98% of the mitochondria are busy making ATP, while a tiny percent might be "resting" or resetting (and may be consuming ATP). But this is a quantitatively negligible energetic drain for the myocyte. This agrees with inferences about tPTPs in isolated mitochondrial suspensions where individual events cannot be seen.
13
In records where we saw 64 tPTP events we also observed 54 Ca 2+ release events that never recovered, and we interpret those as likely permanent PTP events (pPTP). There was some tendency for both tPTP and pPTP to occur later in the 10 min observation period Fig 1J) , especially for pPTP (81% were in the last 4 min). In some myocytes we saw no tPTPs, which is a logical consequence of their stochastic rarity, because those cells showed no difference in the [Ca 2+ ] mito reached at the end of the protocol (Fig 1K) .
Mitochondrial depolarization accompanies tPTP opening.
Brief mPTP opening should depolarize ΔΨ m and cause mitochondrial Ca 2+ release, 13, 20 but it was also proposed that Ca 2+ enters mitochondria via a sub-conductance mPTP opening associated with partial ΔΨ m depolarization. 21 We monitored [Ca 2+ ] mito (with Fluo-8 AM) and ΔΨ m (with tetramethylrhodamine methylester, TMRM) simultaneously, during protocols as in Fig 1E . Figure 2A- Figure I) . Hence, during tPTP opening, the mitochondria retain key matrix metabolites that allow respiratory recovery and repolarization once the pore closes, and this differs from pPTP. One possibility is that tPTP openings have lower pore size vs. sustained pPTP openings (in which molecules of 1,500 Da can permeate).
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Since we see full [Ca 2+ ] mito recovery, it is clear that Rhod-2 (MW 869 Da) does not leave the mitochondrial matrix during tPTP opening. To further test the molecular weight cutoff for tPTP, we loaded myocytes with calcein AM and TMRM to monitor ΔΨ m and tPTP opening. Fig 2C shows (Fig 3A) . This is consistent with our observation that there are no detectable tPTP openings in Ca 2+ -free solution in the absence of SR function (Fig 3D) . Cyclophilin D (CypD) is known to be an important facilitator of mPTP opening.
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Either pharmacological inhibition of CypD by CsA or genetic ablation of the CypD gene abolished tPTP openings during spontaneous SR Ca release (Fig 3A) . So (1 µmol/L) increased tPTP opening frequency 6-fold (10.0 ± 2.6 vs. 1.6 ± 0.6, H 2 O 2 vs. CTL , **p<0.05), but there were no changes in the average time point at which the pore opened (395 ± 45s vs. 463 ± 24s, CTL vs. H 2 O 2 ) or the duration of pore opening (52 ± 8 s vs. 45 ± 6 s, CTL vs. H 2 O 2 ) (Fig 3B-D) . Moreover, the frequency of tPTP opening as a function of [Ca 2+ ] i shows that H 2 O 2 increased mPTP sensitivity for Ca (***P<0.001, Figure 3D ). Taken together, our data indicate that Ca 2+ and moderate oxidative stress via H 2 O 2 synergize in tPTP opening.
To test whether similar tPTP openings could be observed in intact myocytes, we measured CsAsensitive ΔΨ m in electrically stimulated myocytes (1 Hz). The frequency and duration of tPTP openings was comparable in intact vs. permeabilized myocytes (Fig 3B,F vs. Fig 1F,H,I ). These results are consistent with our baseline permeabilized myocyte data reflecting basal physiological levels of tPTP openings. Increasing stimulation frequency from 2 to 4 Hz tended to increase tPTPs (1.0 ± 0.6 vs. 5.5 ± 1.1, not significant in ANOVA; Online Figure IIIA ), but -adrenergic stimulation with isoproterenol significantly increased tPTP opening at 1 Hz (nearly 10-fold), and also reduced tPTP duration by ~50% (Fig 3B and Online Figure III) . Thus, increased work or stress can favor tPTP opening. Ca 2+ -and ROS-induced tPTP are increased in heart failure.
The failing heart exhibits dysregulation of myocyte Ca 2+ handling and increased oxidative stress, which could favor tPTP opening. We measured tPTP in HF myocytes. HF was induced by transverse aortic constriction. Systolic function was substantially depressed after 6-8 weeks assessed by echocardiography (Fig 4A-B ) and hearts were enlarged (heart: body weight) with pulmonary congestion (lung: body weight; Fig 4C) . This is the stage at which we tested tPTP in myocytes.
Using the SR Ca release protocol as in Fig 1E , HF vs. sham myocyte exhibited many more tPTP openings, and these could be suppressed by CsA (Fig 4D) . To test which factor might be responsible for higher tPTP during HF, we measured mitochondrial Ca ] m rise was the same between sham and HF (1.83 ± 0.17 vs. 1.92 ± 0.14, HF vs. Sham; Fig 4E) . However, the ROS sensor DCF (2',7'-dichlorodihydrofluorescein diacetate) indicated that the rate of ROS formation in HF cells was significantly higher than sham, both at rest and during 1 Hz pacing ( Fig  4F) . Given the potent effects of ROS on tPTP (Fig 3B and D) , we suspect that the high tPTP rate in HF could be mediated by increased ROS production. It is possible that the increased number of tPTPs in HF is part of a physiological self-repair mechanism of mitochondria in HF that limits injury to individual mitochondria.
DISCUSSION
The notion of tPTP as a lower conductance and more reversible manifestation of the well-studied and pathological permanent PTP has been suggested by prior work on isolated mitochondria populations, ]. Here we directly demonstrate physiological tPTP openings in individual mitochondria in situ in cardiac myocytes, measure their duration (~60 s) and pore size cutoff (not allowing 600 Da molecules), both of which are quite distinct from pPTP. However, we also found tPTP to have sensitivity to CsA, CypD, MCU blockade, [Ca 2+ ] i , [Ca 2+ ] mito , H 2 O 2 that are similar to pPTP. Thus, our working hypothesis is that tPTP openings (or MitoWinks) share much of the molecular mechanism and machinery that is involved in the more extensively studied pPTP. Bernardi and colleagues suggested that dimeric F 0 F 1 -ATP synthase (complex V) serves also as the pPTP itself, 6, 28 but whether this applies to tPTP will require better resolution of detailed molecular basis of pPTP. Disruption of a reported matrix electrical coupling between mitochondria 29, 30 might contribute to tPTP, but individual mitochondrial function is the simplest interpretation of these MitoWinks.
An attractive possibility is that tPTP is simply an intermediate state on the transition to pPTP, exhibiting smaller channel pore and greater reversibility. This could be functionally analogous to the kissand-run hypothesis of partial, low-conductance vesicle fusion to plasma membrane during exocytosis and neurosecretion.
31, 32
We did not observe transitions from tPTP to pPTP, but those might only reasonably be seen as a delayed calcein or Rhod-2 release after ΔΨ m depolarization. Since tPTP events are so rare, we cannot unequivocally assess this.
We infer that tPTP openings occur in single mitochondria, but confocal resolution limitations mean that fluorescence from other nearby mitochondria can influence signals in our mitochondrion-sized region of interest. Figure 1G is ] mito decline is incomplete. One likely interpretation is that the total fluorescence is from two (or three) individual mitochondria, only one of which exhibits a MitoWink. This spatial constraint does not influence our conclusions.
A major point is that unlike pathological pPTP, these rare tPTP openings are somehow beneficial to a mitochondrion, by allowing a physiological reset by release of excess Ca 2+ and perhaps other accumulated harmful factors, but without losing key larger molecules and without harming cell-wide ATP production. That conclusion is clearly appropriate under our quasi-physiological resting conditions where only 0.02% of mitochondria are simultaneously depolarized in this tPTP mode. This percentage increases with mild ROS exposure (6-fold), 1 Hz pacing with isoproterenol (10-fold) and in basal HF myocytes (24-fold), such that nearly 0.5% of cellular mitochondria would be non-functional at any time. Note also that during a tPTP mitochondria would consume rather than make ATP (via F 0 F 1 -ATPase), 33 which would increase the functional cost of tPTPs on ATP production. So, under in vivo high work-loads combined with pathological stresses, tPTP frequency might become high enough to limit ATP production. Like in control myocytes, there were comparable numbers of tPTP and pPTP openings in HF during the 10 min observation. Thus with the parallel rise in pPTP events in HF or other pathologies, the functional consequences would be further exacerbated, because the pPTP (vs. tPTP) openings are permanent and cumulative.
So, in an individual cardiac mitochondrion how many tPTP events might occur during its normal turnover lifetime (estimated at 17 days 34 )? Our measurements imply one tPTP every 3 to 83 hr (basal HF vs. control), but again this could be more frequent under in vivo stress. Moreover, if these tPTPs represent the turning point between beneficial refreshment vs. a pPTP and mitochondrial death, it will be important to understand these events in more detail.
We were surprised that tPTP openings lasted ~60 s, thinking that less time would be required to release Ca 2+ . While it often required >10 s for [Ca 2+ ] mito to reach a minimum, the longer duration might also allow other, beneficial effects to occur to help reset that mitochondrion. Another, possibly related surprise, was that [Ca 2+ ] mito typically rose faster after tPTP closure than it had before. We propose that during tPTP openings mitochondria free [ uptake in isolated mitochondrial, which was attributed to slow uptake of phosphates. 35 We found that longer tPTP durations had faster subsequent [Ca 2+ ] mito recovery (Online Fig IV) , consistent with this idea. The lack of PTP re-opening as [Ca 2+ ] mito recovers might also be due to loss of mitochondrial Ca This characterization of individual MitoWinks in cardiac myocytes demonstrates a potentially beneficial physiological restorative mPTP event, which contrasts functionally with pPTP openings (that lead to mitochondrial and cell death). These initial studies pave the way for future studies that may define the explicit molecular mechanism (e.g. are tPTP and pPTP different functions of the same proteins?) and how tPTP openings integrate into normal mitochondrial function.
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DISCLOSURES
Novelty and Significance
What Is Known?
 The high-conductance and permanent opening of mitochondrial permeability transition pore (pPTP) causes mitochondrial injury and cell death.
 Unlike permanent opening of PTP, transient and low--conductance opening of PTP (tPTP) was proposed as protective against pathological Ca overload.
 Direct characterization of tPTP opening in cardiac mycoytes still remained unclear.
What New Information Does this Article Contribute?
 tPTP opening in cardiac myocytes is rare (only 0.02% of mitochondria is in tPTP at any given time), last for ~57 s, and respond to PTP regulatory factors like Ca, reactive oxygen species, cyclophilin D and cyclosporine A.
 When tPTP opens, molecules > 600 Da can't pass through (smaller pore than full PTP), and mitochondria can retain small metabolic molecules (e.g. NADH) during tPTP.
 tPTP opening frequency increased under higher work or pathological conditions, which could be a physiological mitochondrial self--repair mechanism.
 Characterization of tPTP in cardiac mycoytes suggests a physiologically beneficial role of tPTP opening (vs. full pPTP opening). and the small pore size are in striking contrast to the well--studied permanent PTP openings that lead to mitochondrial dysfunction and cell death. However, the Ca 2+ , ROS, cyclophilin D and cyclosporine A sensitivity of tPTP resemble those of pPTP. We conclude that these new tPTP openings are mediated by the same molecular components as pPTP, but instead of being the harbinger of death, are beneficial for mitochondrial (and cell) survival by allowing individual mitochondria to reset themselves with negligible overall energetic cost. ]. For plasma membrane permeabilization, cells were exposed to saponin (50 µg/ml; 30 sec) which was then washed off, in standard intracellular relaxing solution containing (in mmol/L) HEPES 10, K-aspartate 135, MgCl2 0.7, EGTA 2, reduced glutathione 10, MgATP 5, glucose 10, pH 7.2. 
Solutions
Confocal imaging scanning
Mitochondrial Rhod-2 and TMRM fluorescence were measured (Zeiss LSM 5 live confocal microscope, 60X water-immersive objective) in 2-dimensional imaging mode with excitation at 532 nm, with emission at > 560 nm. Fluo-4, Fluo-8 and FAD autofluorescent signals were measured with same confocal (488 nm excitation, emission at 530 ± 15 nm). Calcien signals were collected using excitation at 488 nm and emission at 530 ± 15 nm. Time-lapse x,y images were acquired at 512 bit resolution and at the sampling rate of 507 ms per frame. Region of interest size for analysis of single (or two) mitochondria was ~12 µm, centered on an identifiable mitochondrion.
Chemicals and statistics
Indicators were obtained from Invitrogen (Eugene, OR), Ru360 from Calbiochem (La Jolla, CA). Data are presented as mean ± SE of n measurements. Comparison between groups used Student's t-test, One-Way ANOVO and Two-Way ANOVO (significant at p<0.05) Heart failure model We used transverse aortic constriction in mice to induce HF. Briefly, after a 5-nmol/L thoracotomy is made lateral to the left sternal border, two loose knots were tied around the transverse aorta, and a blunt 27-gauge needle was then placed parallel to the transverse aorta and inside the first loose knot. The first knot was then tied tightly, followed by the second. Immediately after, the needle was taken out, yielding a constriction of 0.4mm in diameter. With this amount of ligation, HF developed in 6-8 weeks after surgery. Experiments with cardiac cells were performed 8 weeks post-surgery.
Echocardiography
Mice were anesthetized in an isoflurane chamber prior to placing them in the supine position on an ECG platform. The paws of the mouse were taped down with electrode cream onto the ECG sensors, while the nose was connected to a nozzle that delivers 95% O2 / 5% CO2 with a concentration of isoflurane that maintains the mouse's heart rate at 550 ± 50 bpm. M-mode echocardiography was performed a day before surgery and eight weeks after surgery using the Visualsonics Vevo 2100 system. 
